Jodie Pope Morrison, President and CEO at Tokai Pharmaceuticals Inc (TKAI), sold 16,000 shares at $13.83 ($220K) on 2015-06-26, disclosed to the SEC on 2015-06-30.
Scheduled sale ($220k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.83 | 8,000 | $111K | 50.2% |
| 2 | $13.70 | 8,000 | $110K | 49.8% |
| Total | $13.77 avg | 16,000 | $220K | 100% |
| Filing → |
| QTTB | SELL | 2025-12-04 | $156K | — | Filing → |
| QTTB | SELL | 2025-08-28 | $19K | — | Filing → |
| TKAI | SELL | 2015-07-30 | $172K | — | Filing → |